Manuscripts
Showing 1552 manuscripts.
Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women
Citation
Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women. American Journal of Clinical Nutrition. 2008. 87: 1639-49. PMID: 18541551Year
2008
Journal
American Journal of Clinical Nutrition
Lopinavir exposure with an increased dose during pregnancy
Citation
Alice M Stek, Edmund Capparelli, ChengCheng Hu, Sandra K Burchett, Diane T Holland, Elizabeth Smith, Sreedhar Gaddipati, Jennifer S Read, PACTG 1026s Study Team, Mark Mirochnick, Brookie M Best. Lopinavir exposure with an increased dose during pregnancy. Journal of Acquired Immune Deficiency Syndromes. 2008. 49: 485-91. PMID: 18989231Year
2008
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1026S
Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095
Citation
Bruce R. Schackman, Heather Ribaudo, Amy Krambrink, Valery Hughes, Daniel R. Kuritzkes, Roy (Trip) Gulick. Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095. Journal of Acquired Immune Deficiency Syndromes. 2007. 46: 547-54. PMID: 18193496Year
2007
Journal
Journal of Acquired Immune Deficiency Syndromes
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients
Citation
Rahul P. Bakshi, Fayez Hamzeh, Ian Frank, Joseph J. Eron, Ronald J. Bosch, Susan L Rosenkranz, Yoninah S. Cramer, Michael Ussery, Charles Flexner. Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients. AIDS Research and Human Retroviruses. 2007. 23: 1360-5. PMID: 18184078Year
2007
Journal
AIDS Research and Human Retroviruses
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment
Citation
James Weihe, Rory P. Remmel, Giovanni Schifitto, David Katzenstein, Jiameng Zhang, David B. Clifford, Scott Evans, Ned Sacktor, David M. Simpson, Linda L. Millar, Vivian (Lang) M. Hung, Eric N. Miller, Elizabeth (Betsy) Smith, Ronald J. Ellis, Victor G. Valcour, Elyse J. Singer, Christina M. Marra, Dennis Kolson. A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology. 2007. 69: 1314-21. PMID: 17652642Year
2007
Journal
Neurology
A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain
Citation
Scott Evans, David M. Simpson, Doug Kitch, Agnes King, David B. Clifford, Bruce A. Cohen, Justin C. McArthur. A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. Public Library of Science Clinical Trials. 2007. 2: e551.Year
2007
Journal
Public Library of Science Clinical Trials
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of adult clinical trials group 384
Citation
Michael P. Dube, Lauren Komarow, Kathleen Mulligan, Steven K. Grinspoon, Robert A. Parker, Gregory K. Robbins, Ronenn Roubenoff, Pablo Tebas. Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of adult clinical trials group 384. Journal of Acquired Immune Deficiency Syndromes. 2007. 45: 508-14.Year
2007
Journal
Journal of Acquired Immune Deficiency Syndromes
Discrete stochastic models for compliance analysis based on an AIDS Clinical Trial Group (ACTG) study
Citation
Junfeng Sun, Haikady N. Nagaraja, Nancy Radcliffe Reynolds. Discrete stochastic models for compliance analysis based on an AIDS Clinical Trial Group (ACTG) study. Biometrics. 2007. 49: 731-41.Year
2007
Journal
Biometrics
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV
Citation
Grace McComsey, Michelle A. Kendall, Pablo Tebas, Susan Swindells, Evelyn Hogg, Beverly L. Alston-Smith, Carol Suckow, Geetha Gopalakrishnan, Constance A. Benson, David Alain Wohl. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS. 2007. 21: 2473-82.Year
2007
Journal
AIDS
Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384
Citation
Michael P. Dube, Robert A. Parker, Kathleen Mulligan, Pablo Tebas, Gregory K. Robbins, Ronenn Roubenoff, Steven K. Grinspoon. Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384. Clinical Infectious Diseases. 2007. 45: 120-6. PMID: 17554712Year
2007
Journal
Clinical Infectious Diseases